NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
09/12/2023
Back to search
Official data from USPTO
HEMA BIOLOGICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
HEMA BIOLOGICS
ST13
US500000087435600Class
42
Filing
87435600
Registration
5435087
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
09/12/2023
Trademark type
Word
Nice classes
42
Filing date
05/03/2017
Registration date
03/27/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/12/2023
Last transaction
09/12/2023
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Supplemental Register
First use anywhere
07/22/2016
First use in commerce
07/22/2016
Drawing code
4
Owner type
16
Owner location
Louisville, KY
Examiner
JONES, JACQUELYN
Law office
N20
Current location
TMO LAW OFFICE 120
Holders and representatives
Holders
Hema Biologics, LLC
Representatives
Amy B. Berge Gray Ice Higdon, PLLC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Providing scientific and medical research information in the field of rare blood disorders
Publications
History of USPTO decisions and trademark events.
19 publications found
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
09/12/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/12/2023
ES8R
TEAS SECTION 8 RECEIVED
04/21/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/27/2023
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
03/27/2018
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/20/2018
ALIE
ASSIGNED TO LIE
02/16/2018
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
02/01/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
02/01/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/01/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
02/01/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/01/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/07/2017
GNRT
NON-FINAL ACTION E-MAILED
08/07/2017
CNRT
NON-FINAL ACTION WRITTEN
08/07/2017
DOCK
ASSIGNED TO EXAMINER
07/31/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/09/2017
NWAP
NEW APPLICATION ENTERED
05/06/2017
Continuous trademark protection
Get notified about every new filing that threatens HEMA BIOLOGICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.